WS #10485
Lilly revenue surged 45% to $65B on Mounjaro/Zepbound; orforglipron submitted for approval; new US pricing pact.
Eli Lilly Revenue Surge
Lilly revenue surged 45% to $65B on Mounjaro/Zepbound; orforglipron submitted for approval; new US pricing pact.